| HOME >> BIOLOGY >> TECHNOLOGY |
Regulatory authorities 108
SUKL - Czech Republic 108
NIL - Poland 109
RZN - Russian Federation 110
Clinical trial regulation 111
Czech Republic 112
Poland 116
Russian Federation 116
Legislation 119
Poland removes tax block for clinical trials 119
Decree no. 226/2008 on good clinical practices - Czech Republic 119
Russia 119
Outlook 120
Chapter 4 Appendix 122
Introduction to clinical trials 122
Clinical trial phases 122
Phase I 122
Phase II 122
Phase III 123
Phase IV 123
What is a clinical trial 123
Clinical trials of pharmaceutical agents 124
Types of clinical trial 125
Pilot studies 125
Proof of concept (PoC) trials 125
Randomized clinical studies 125
Controlled clinical trials 125
Parallel studies 126
Parallel group trials 126
Cohort studies 126
Case control studies 126
Role of the chief investigator 127
Clinical trial protocol and procedure 127
Determination of the clinical trial size 128
Role of the coordinating centre and trials unit 128
Role of the trial coordinator 128
The trial principle investigator 129
Forms and data management 129
Trial data analysis and evaluation 130
Ethical issues and conduct of clinical trial research 130
Interpretation and publication of clinical trial results 131
Principle regulatory agencies 131
The European Agency for the Evaluation of Medicinal Products (EMEA) 131
The United States Food and Drug Administration (US FDA) 131
Japanese Ministry of Health, Labor and Welfare (MHLW) 132
Methodology statement 133
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |